This inventor holds 1 USPTO granted patent. Top assignee: University of Houston System. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Chin-Yo Lin: Inventor of a Potentially Less-Toxic Cancer Treatment
Introduction
Chin-Yo Lin is an inventor based in Kingwood, Texas, whose patent work explores small-molecule compounds that target liver X receptors (LXRs). His listed patent describes a potential approach to cancer treatment designed to affect tumor cells while limiting activity against dividing non-malignant cells.
Latest Patents
Lin is associated with 1 patent, titled “Small Molecule Liver X Receptor Modulators and Uses Thereof.” The patent describes LXR modulators and derivatives that target metabolic pathways favored by cancer cells and activate a cell-death mechanism distinct from those induced by conventional chemotherapy.
The proposed compounds may offer a less-toxic alternative to chemotherapy or be used alongside it to improve treatment efficacy and reduce the likelihood of resistance. The patent also discusses their potential use as second-line treatments when chemotherapy is ineffective or cancer cells become resistant.
Career Highlights
Lin’s listed work is associated with the University of Houston System. His patent focuses on a therapeutic strategy that seeks to exploit differences between tumor cells and non-malignant cells, with the aim of supporting more selective cancer treatment.
Collaborations
Scott R. Gilbertson is identified as Lin’s coworker. Their association is noted alongside Lin’s patent-related work connected with the University of Houston System.
Conclusion
Chin-Yo Lin’s patent presents liver X receptor modulation as a potential way to target cancer-cell metabolism and complement or provide an alternative to chemotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
